264 related articles for article (PubMed ID: 16151532)
1. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin.
Sudhakar A; Nyberg P; Keshamouni VG; Mannam AP; Li J; Sugimoto H; Cosgrove D; Kalluri R
J Clin Invest; 2005 Oct; 115(10):2801-10. PubMed ID: 16151532
[TBL] [Abstract][Full Text] [Related]
2. Type IV collagen α1-chain noncollagenous domain blocks MMP-2 activation both in-vitro and in-vivo.
Sudhakar YA; Verma RK; Pawar SC
Sci Rep; 2014 Mar; 4():4136. PubMed ID: 24670518
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor.
Nyberg P; Xie L; Sugimoto H; Colorado P; Sund M; Holthaus K; Sudhakar A; Salo T; Kalluri R
Exp Cell Res; 2008 Nov; 314(18):3292-305. PubMed ID: 18775695
[TBL] [Abstract][Full Text] [Related]
4. Regulation of COX-2 mediated signaling by alpha3 type IV noncollagenous domain in tumor angiogenesis.
Boosani CS; Mannam AP; Cosgrove D; Silva R; Hodivala-Dilke KM; Keshamouni VG; Sudhakar A
Blood; 2007 Aug; 110(4):1168-77. PubMed ID: 17426256
[TBL] [Abstract][Full Text] [Related]
5. FAK and p38-MAP kinase-dependent activation of apoptosis and caspase-3 in retinal endothelial cells by alpha1(IV)NC1.
Boosani CS; Nalabothula N; Munugalavadla V; Cosgrove D; Keshamoun VG; Sheibani N; Sudhakar A
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4567-75. PubMed ID: 19443723
[TBL] [Abstract][Full Text] [Related]
6. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins.
Sudhakar A; Sugimoto H; Yang C; Lively J; Zeisberg M; Kalluri R
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4766-71. PubMed ID: 12682293
[TBL] [Abstract][Full Text] [Related]
7. Extra cellular matrix derived metabolite regulates angiogenesis by FasL mediated apoptosis.
Verma RK; Gunda V; Pawar SC; Sudhakar YA
PLoS One; 2013; 8(12):e80555. PubMed ID: 24324608
[TBL] [Abstract][Full Text] [Related]
8. Cloning, purification, and characterization of a non-collagenous anti-angiogenic protein domain from human alpha1 type IV collagen expressed in Sf9 cells.
Boosani CS; Sudhakar A
Protein Expr Purif; 2006 Oct; 49(2):211-8. PubMed ID: 16631378
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of recombinant RTS-jerdostatin on integrin α1β1 function during adhesion, migration and proliferation of rat aortic smooth muscle cells and angiogenesis.
Bolás G; de Rezende FF; Lorente C; Sanz L; Eble JA; Calvete JJ
Toxicon; 2014 Mar; 79():45-54. PubMed ID: 24418176
[TBL] [Abstract][Full Text] [Related]
10. Enhancing integrin α1 inserted (I) domain affinity to ligand potentiates integrin α1β1-mediated down-regulation of collagen synthesis.
Shi M; Pedchenko V; Greer BH; Van Horn WD; Santoro SA; Sanders CR; Hudson BG; Eichman BF; Zent R; Pozzi A
J Biol Chem; 2012 Oct; 287(42):35139-35152. PubMed ID: 22888006
[TBL] [Abstract][Full Text] [Related]
11. Selective binding of integrins from different renal cell types to the NC1 domain of alpha3 and alpha1 chains of type IV collagen.
Aggeli AS; Kitsiou PV; Tzinia AK; Boutaud A; Hudson BG; Tsilibary EC
J Nephrol; 2009; 22(1):130-6. PubMed ID: 19229828
[TBL] [Abstract][Full Text] [Related]
12. Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.
Aikio M; Alahuhta I; Nurmenniemi S; Suojanen J; Palovuori R; Teppo S; Sorsa T; López-Otín C; Pihlajaniemi T; Salo T; Heljasvaara R; Nyberg P
PLoS One; 2012; 7(12):e51044. PubMed ID: 23227231
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of elastin peptide-mediated angiogenic signaling mechanism(s) in choroidal endothelial cells by the α6(IV)NC1 collagen fragment.
Gunda V; Verma RK; Sudhakar YA
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):7828-35. PubMed ID: 24194191
[TBL] [Abstract][Full Text] [Related]
14. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins.
Senger DR; Claffey KP; Benes JE; Perruzzi CA; Sergiou AP; Detmar M
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13612-7. PubMed ID: 9391074
[TBL] [Abstract][Full Text] [Related]
16. T7 peptide inhibits angiogenesis via downregulation of angiopoietin-2 and autophagy.
Wang F; Dong X; Xiu P; Zhong J; Wei H; Xu Z; Li T; Liu F; Sun X; Li J
Oncol Rep; 2015 Feb; 33(2):675-84. PubMed ID: 25483829
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor angiogenesis by tumstatin: insights into signaling mechanisms and implications in cancer regression.
Sudhakar A; Boosani CS
Pharm Res; 2008 Dec; 25(12):2731-9. PubMed ID: 18551250
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of the cytoplasmic domain of the integrin {alpha}1 subunit in endothelial cells.
Abair TD; Bulus N; Borza C; Sundaramoorthy M; Zent R; Pozzi A
Blood; 2008 Oct; 112(8):3242-54. PubMed ID: 18647959
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.
Eikesdal HP; Sugimoto H; Birrane G; Maeshima Y; Cooke VG; Kieran M; Kalluri R
Proc Natl Acad Sci U S A; 2008 Sep; 105(39):15040-5. PubMed ID: 18818312
[TBL] [Abstract][Full Text] [Related]
20. Targeting α1 inserted domain (I) of α1β1 integrin by Lebetin 2 from M. lebetina transmediterranea venom decreased tumorigenesis and angiogenesis.
Morjen M; Othman H; Abdelkafi-Koubaa Z; Messadi E; Jebali J; El Ayeb M; Abid NS; Luis J; Marrakchi N
Int J Biol Macromol; 2018 Oct; 117():790-799. PubMed ID: 29870815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
